Global BCG Vaccines Market: By Age Group (Adult, Paediatrics), Application (Bladder Cancer and TB) By Channel (Retail Pharmacy, Hospital Pharmacy and Online) and Geography, and by Region (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)—Forecast till 2028

Description

 Market Overview:

The global BCG vaccines market platform market size was valued at USD 71 billion in 2022 and is projected to expand at a CAGR of 4.5% from 2023 to 2028. The growth of the market is majorly accredited to the rising incidences of TB patients, the large production of vaccines regarding the disease, rising awareness among the citizens of the country, together with the expansion of the healthcare sector. These variables are set to expand the market share of the vaccine industry.

Market Size for Global BCG Vaccine Market on the Basis of Revenues in USD Bn, 2018-2023

Source: Maven Market Research

What Factors are Leading to the Growth of the Global BCG Vaccines Market?

• The innovations in vaccine manufacturing technologies have enhanced the efficiency and effectiveness of BCG vaccines by improving the production processes and better supply chain management that contribute to the global market expansion.
• The education initiatives, particularly in high-burden regions of the country, coupled with increased awareness about TB and the benefits of BCG vaccination through public health campaigns have led to higher vaccination rates, and have enhanced the growth of the market.
• It is witnessed that international health organizations, such as the WHO, continuously take initiatives towards TB eradication through extensive immunization programs. The growing awareness about vaccinations among the citizens has also positively impacted the growth of the market.

Which Industry Trends have been Fueling the Growth of the BCG Vaccines Market?

Performance By Key Players:  Numerous key players are investing significantly in research and development to improve vaccine efficacy and safety, addressing emerging TB strains and enhancing production efficiency. Sanofi Pasteur, a major player in the BCG vaccine market, focuses on innovation and maintaining high standards of vaccine safety and efficacy. The growth and the competitive edge among the key players are bringing better products into the market.

Growing TB Incidences:  The existence of high TB incidence rates directly correlates with increased demand for BCG vaccines, driving the growth of the market. Despite the global efforts to control TB, the disease remains prevalent in many developing regions. These variables are predicted to augment the growth of the healthcare as well as the vaccination market.

Expansion of HealthCare Infrastructure: The rising investments in healthcare infrastructure, especially in developing countries like India, have improved vaccine accessibility and distribution. This shift has enhanced the healthcare facilities and trained personnel to ensure effective vaccine administration leading to propel the growth of the market.

What is the Current Structure of the Global BCG Vaccines Market?

By End-User Type, healthcare Sector has Dominated the Largest Market Share in the Global BCG Vaccines Market

The BCG vaccine market has observed major growth due to the healthcare sector. The hospitals and clinics provide regular immunizations to newborns and high-risk populations. These settings offer the infrastructure and trained personnel necessary for safe vaccine administration. The installations of the vaccines are done by the governments to prevent the spread of TB.

By Application

In 2022, the segment with the biggest market share was TB. This is explained by the growing number of cases of tuberculosis and the increased need for the BCG vaccination to prevent TB. For example, in February 2022, the Government of India’s Ministry of Health and Family Welfare published a report titled “India TB Report 2022.” According to the report, 31% of tuberculosis cases globally are in children, making it a serious problem. As a result, the target group is anticipated to get more vaccinated against BCG because ofpaediatricians’ increasing BCG vaccination rate, which will ultimately spur segment expansion.

By Channel Type, Public Distribution Channels Dominated the Largest Market Revenue in the Global Market

The BCG vaccine market is divided into hospital pharmacy, internet pharmacy, and retail pharmacy segments based on the distribution channel. In 2022, the retail pharmacy sector had the biggest market share. When treating complex illnesses like bladder cancer and TB, chemists can provide guidance.They might also offer general advice on nutrition, stress reduction, and exercise, all of which would help draw in and keep both new and returning customers for their products. The retail pharmacy sector is growing because of all these causes.

By Region Type, North American Region Leads the Market

The major regions of North America, especially the USA, are focusing on maintaining immunity among high-risk groups, such as healthcare workers and immigrants from high TB prevalence countries. Moreover, the regions of Asia-Pacific are making it a significant market for BCG vaccines. It is observed that government initiatives and international collaborations are aiming at eradicating TB to fuel the demand of the BCG vaccines market.

Competitive Analysis

However, the global BCG vaccine market is driven by the constant challenge of TB, government initiatives, technological advancements, and rising awareness. It is observed that regional variations in TB incidences and healthcare infrastructures are influencing the growth of the market positively. Hence, the BCG vaccine market is expected to witness sustained growth, playing a pivotal role in the global public healthcare sector in the forthcoming years.Key players operating in the market are Serum Institute of India Pvt. Ltd., Microgen, Merck & Co., Inc., Japan BCG Laboratory, and AJ Biologics Sdn Bhd. The market participants persistently work towards new product launches, collaborations, M&A activities, and other strategic alliances to gain new market avenues.

Market Segmentation

Global BCG Vaccines Market, By Application

• TB
• Bladder Cancer

Global BCG Vaccines Market, By End User Type

• Hospitals
• Clinics
• Research Institutes
• Diagnostic Centers

Global BCG Vaccines Market, By Channel Type

• Direct Sales
• Distributors
• Online Sales
• Retail Pharmacies

Global BCG Vaccines Market, By Region Type

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France

Asia-Pacific

• China
• India
• Japan
• South Korea
• Australia

Latin America

• Brazil
• Mexico
• Argentina

Middle East & Africa

• South Africa
• UAE

Key Players

• Merck & Co., Inc.
• Sanofi Pasteur
• Japan BCG Laboratory
• Serum Institute of India Pvt. Ltd.
• China National Biotec Group (CNBG)
• InterVax Ltd.
• GreenSignal Bio Pharma Pvt. Ltd.
• Statens Serum Institut
• AJ Biologics Sdn Bhd
• Biomed Lublin
• BB-NCIPD Ltd.
• BioFarma
• Taj Pharmaceuticals Limited